Capacite: 19% YoY revenue growth, but consolidated PAT slips 7% as margins compress
PAT -6.85% YoY · revenue +19.31% · margins compressing
₹770.93 Cr
+19.31% YoY
₹47.56 Cr
-6.85% YoY
6.13%
-1.7pp YoY
₹5.62
Capacite Infraprojects' consolidated revenue from operations rose 19.3% YoY to ₹770.93 Cr (and 22.6% QoQ from Q1 FY27's ₹628.93 Cr), tracking close to management's maintained FY27 target of 20% YoY revenue growth. Consolidated PAT, however, fell 6.9% YoY to ₹47.56 Cr from ₹51.06 Cr in Q2 FY26, even as it rose 19.4% sequentially off Q1's weak ₹39.84 Cr base — the YoY decline is the material read, since Q1's own base was depressed. No consensus estimates specific to this quarter turned up in available coverage (results were announced today, November 4, 2026, too fresh for preview pieces), so vsStreet is unknown; no separate management press release was available in the record to cross-check against the filing.
Q2 FY-2027 vs prior quarters
The gap between strong topline growth and a weaker bottom line sits in margins: operating margin (EBITDA/revenue) came in at roughly 15.45%, below the floor of management's own 15.5-16.5% FY27 guidance band and down from 16.76% a year ago, while net margin compressed to 6.17% from 7.85% YoY. Both were roughly flat sequentially against Q1's 15.69%/6.23%, so this is a YoY phenomenon rather than fresh in-quarter deterioration, consistent with cost of materials and construction expenses growing faster than revenue. Net debt also widened to approximately ₹530 Cr as of September 30, 2026 from about ₹320 Cr at March 31, 2026, as H1 capex (₹124.96 Cr against a raised FY27 target of ₹193 Cr) and a combined ₹208.9 Cr build-up in trade receivables and contract assets absorbed operating cash flow — a trajectory running counter to the 'net debt-free in 8 quarters' target management set on the Q1 FY27 call.
The stock went into the print at ₹157.94, down 11.6% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Leadership churn in-quarter — CEO resignation (Aug 18, 2026) followed by appointment of four new CEOs (Sep 9, 2026)
Standalone PAT ₹45.97 Cr on revenue ₹650.46 Cr, EPS ₹5.43 (vs consolidated EPS ₹5.62)
FY27 revenue growth target 20% YoY, maintained. EBITDA margin 15.5–16.5% for FY27. CapEx raised to ₹193 Cr (from ₹165 Cr). Non-core asset monetization ₹50 Cr FY27. Net debt-free target in 8 quarters.
— This quarter: missed
The quarter also saw leadership turnover: the Director-Operations & CEO resigned on August 18, 2026, and the company appointed four new CEOs on September 9, 2026. On results day, the board separately approved two new overseas step-down subsidiaries (Dubai, UAE at 75% CIL stake, and a wholly-owned Uganda entity) to pursue EPC work outside India, while order wins — a ₹306 Cr Puravankara contract and a ₹368.98 Cr Chennai Metro contract — landed just after the quarter closed and will show up in Q3 FY27, not these numbers. Management's cautiously optimistic short-term tone from the Q1 call will need re-confirmation against this quarter's margin undershoot on the upcoming earnings call.
W1
FY27 EBITDA margin guidance of 15.5-16.5% — Q2 printed just below at ~15.45%; watch Q3 for recovery
W2
Net debt trajectory toward the 'debt-free in 8 quarters' target — debt rose ~₹210 Cr in H1 FY27 to ~₹530 Cr, the wrong direction so far
W3
New CEO team's execution on recently secured ₹306 Cr Puravankara and ₹368.98 Cr Chennai Metro contracts in Q3 FY27
Consolidated PBT (₹63.88 Cr) = pre-JV profit (₹62.29 Cr) + share of JV/associate profit (₹1.59 Cr); total net profit of ₹47.5636 Cr includes NCI loss of ₹(0.18) Cr, so owners' share PAT is slightly higher at ₹47.74 Cr. No exceptional/one-off P&L items in current or year-ago quarter, so adjusted YoY PAT growth equals reported. Auditors issued a qualified conclusion (both standalone and consolidated) on one receivable (₹1,155.93 Lakh) and flagged ₹5,492.76 Lakh of long-outstanding receivables/contract assets under legal recovery — a balance-sheet/audit matter, not a P&L adjustment.
Record revenue, profit decline: Capacite's margin squeeze persists
Highest-ever revenue of ₹771 Cr masks a troubling divergence—net profit fell 6.8% year-on-year despite 19.3% growth at the top line. Management maintained guidance but acknowledged commodity headwinds remain unresolved, flagging a Q4 revisit as likely.
₹771 Cr
+19.3% YoY; highest ever
₹47.6 Cr
-6.8% YoY; ₹51 Cr prior year
15.5%
Mid-guidance band; compressed from prior year
₹13,013 Cr
4+ quarters visibility at current run-rate
The quarter presents a textbook study in divergence. Revenue hit an all-time high of ₹771 crore, up 19.3% year-on-year, yet net profit fell 6.8% to ₹47.6 crore. The company maintained full-year guidance on all three fronts—revenue ₹4,500 crore, EBITDA margin 15.5–16.5%, cash PAT 10.5–11.25%—but the print reveals operational leverage is missing. Commodity inflation—aluminum formwork up 40%, steel up 30% versus pre-war levels—is only partially offset by contractual escalation clauses, leaving a margin squeeze that management flagged as likely to revisit in Q4 if prices do not stabilize.
Where the profit went
The H1 picture is even starker. Half-year PAT stands at ₹87 crore versus ₹98 crore in H1 FY26—down 11%—despite H1 revenue rising 13%. The gap traces to three forces. First, commodity escalation: the pass-through gap narrowed from 35% in Q1 to 2% in Q2, but absolute prices (aluminum at ₹14,500 per sqm versus ₹10,500 pre-war) remain materially elevated. Second, milestone billing delays on CIDCO (board clearance pending for profit recognition). Third, prior-year non-core gains—bad debt recovery and asset sales—that inflated H1 FY26 PAT and do not recur this year. Management confirmed it has ₹48 crore in assets marked for sale in FY27, but timing is fluid. Organic profit is roughly flat year-on-year, which is why the reported PAT decline looks worse than the operational reality.
Highest-ever quarterly revenue of ₹771 Cr; 19% YoY growth
SupportedDelivered ₹770.9 Cr, YoY +19.3%. Order book ₹13 Cr at Sept 30 supports trajectory.
EBITDA margin 15.5% Q2; PAT margin 6.1%; both on track
OverstatedDelivered OPM 15.4%, NPM 6.1%. Margin at low end of 15.5–16.5% guidance band; cash PAT ~₹83 Cr (10.7%) in-band, but reported PAT down 6.8% YoY.
Order inflow ₹2,487 Cr YTD; FY28 target ₹4,000 Cr achievable
SupportedOrder book ₹13,013 Cr as of Sept 30; bid pipeline ₹3,270 Cr. FY27 run rate ~₹2,800 Cr annualized.
Commodity cost escalation mitigated by contractual pass-through; 100% private sector has pass-through
PartialGap narrowed Q1→Q2 (35%→2%). But aluminum at ₹14,500/sqm vs ₹10,500 pre-war remains material. Government contracts use WPI escalation; recovery lag persists.
Strong execution; working capital cycle reduced 11 days QoQ
SupportedContract assets ₹2,279 Cr (18–20% of prior 12M revenue). Debtors ₹1,300 Cr at 120 days. WC days fell 11 days Q2 vs Q1; trend positive but absolute cycle still elevated.
What changed on this call
New large client: Mahindra Lifespace added to portfolio—mixed residential—signals market confidence in execution capability.
NGT suspension risk quantified: 15–20 days expected Nov 5–20 embargo. Signature Global run-rate ₹15 Cr/month implies ₹7–10 Cr Q3 revenue miss if extended.
Order book quality upgraded: 54% public (₹7 Cr), 46% private (₹6 Cr). Private sector skew higher-margin vs prior mix; recent wins (Mahindra Lifespace, Raymonds) reinforce.
Working capital trajectory confirmed: 11-day QoQ reduction to 130–135 days. Debtors ECL provisions normalized post-Q1.
Margin guidance caveated for Q4 revisit: Management held firm on 15.5–16.5% EBITDA but acknowledged revisit likely if commodity prices do not stabilize.
How the street is positioned
The stock trades at ₹179.94 (as of 2026-11-06), down 61.3% from its all-time high of ₹465 but up 24.35% from its 52-week low of ₹144.70. It sits above its 20-day moving average (₹162.19) but materially below both the 50-day (₹182.97) and 200-day (₹218.44) averages—a bearish technical posture. RSI 59.2 is neutral; volume is increasing. FII ownership has declined 0.8 percentage points to 14.16% quarter-on-quarter, while DII remain stable at 7.72% and the promoter holds steady at 31.69%. The 61% drawdown from the all-time high reflects market frustration with profit growth lagging revenue growth, but the 24% bounce from the lows suggests some bottom-fishing on the order book visibility thesis. The test is whether Q3–Q4 can deliver profit growth that justifies the order book.
Order book ₹13 Cr (4+ quarters visible); bid pipeline ₹3,270 Cr supports FY28 ₹4,000+ Cr target
Revenue guidance ₹4,500 Cr FY27 on track (₹2,500+ Cr in 9M delivered)
Working capital improving: 11-day QoQ reduction; debtors normalized post-Q1 provisions
New clients (Mahindra Lifespace) + order book mix skew 46% private (higher-margin)
Reported PAT down 6.8% YoY despite 19% revenue growth—margin compression clear
Commodity escalation gap narrowed to 2% but prices still ₹4,000/sqm above pre-war
Margin guidance caveated for Q4 revisit; management flagging downside scenario
NGT suspension recurring risk (Signature Global ₹15 Cr/month; 15–20 day ban expected Nov 5–20)
FII ownership declining (-0.8pp); stock down 61% from ATH, up only 24% from 52w low
Commodity inflation unresolved
HighAluminum +40%, steel +30% vs pre-war. Gap narrowed to 2% but prices still elevated. If government WPI does not track market inflation, margin miss on fixed-price government contracts (54% of book). Q4 revisit flagged by management signals low conviction on margin recovery.
NGT suspension recurring
HighSignature Global suspended ~15 days Q2; 20-day ban expected Nov 5–20. Run rate ₹15 Cr/month; each ban costs ₹7–10 Cr revenue. Risk recurs in Q4 during election period. Uncontrollable per management.
Working capital intensity remains high
MediumContract assets ₹2,279 Cr (~18–20% of trailing 12M revenue). Debtors ₹1,300 Cr at 120 days. Milestone billing delays on CIDCO (board clearance pending) could compress H2 collections and defer profit realization.
Order execution delays
MediumCIDCO profit pending board approval (pushed out past Q2). IIT Bombay only 13% of order (₹70 Cr of ₹550 Cr) handed over; land delays. If execution lags, Q3–Q4 revenue targets at risk.
Labor availability during elections
MediumUP elections Q4 FY27. Management factored ₹45–50 Cr revenue loss, but if lockdown extends or election cycle lengthens, impact could exceed estimate. All projects across India exposed.
Margin guidance revision
LowIf Q3 commodity prices remain elevated or NGT suspensions extend, management will likely cut 15.5–16.5% EBITDA target in Q4. Early signal to watch; reversal would erode credibility for FY28 guidance.
1 · Commodity price stabilization (aluminum, steel)
Q3 pricing will determine whether the 2% escalation gap holds or widens. If prices stay elevated (aluminum >₹14,000/sqm), margin recovery stalls and Q4 guidance cut is likely. This is the single biggest variable for Q3 earnings.
2 · Signature Global NGT recovery post-ban
20-day suspension expected Nov 5–20. Once relief granted, run rate should return to ₹15 Cr/month (or accelerate post-ban if backlog builds). Execution discipline on pent-up demand validates management's operating plan.
3 · CIDCO milestone clearance & H2 ramp
Board meeting cleared profitability in Q2; full profit recognition now pending formal approval. H2 targeting 35–40% run-rate increase to ₹600 Cr FY27 (from ₹177 Cr H1 = ₹30 Cr/month current). Confirmation is critical for margin recovery (higher-margin project).
4 · MHADA revenue progression
25 towers handed; targeting ₹4,200–4,300 crore over project life. Q3–Q4 should show clear ramp. Sectors 8–9 filing underway. Speed of handover and milestone releases signal project momentum.
5 · FY28 order inflow & bid pipeline wins
Bid pipeline ₹3,270 Cr; company targeting ₹1,000 Cr inflow for FY28 (vs ₹2,487 Cr YTD FY27). Q3–Q4 wins will validate ₹4,000+ crore FY28 revenue guidance. Watch for any new large clients beyond Mahindra Lifespace.
Capacite's Q2 is a paradox: the highest revenue ever, paired with declining profit year-on-year. The company is executing well on order growth (₹13 crore book, ₹3,270 Cr bid pipeline), working capital (11-day QoQ improvement), and client diversification (Mahindra Lifespace entry). But the 19% revenue growth met with 6.8% profit decline is a red flag on operational leverage and a signal that commodity inflation is outpacing contractual escalation clauses, at least for now.
Management maintained full-year guidance on all three fronts—revenue ₹4,500 crore, EBITDA margin 15.5–16.5%, cash PAT 10.5–11.25%—but flagged Q4 as a revisit point. That transparency is credible, but it also signals the company itself is uncertain on margin recovery until commodity prices stabilize. The stock's 61% drawdown from the all-time high is likely overcooked given the order visibility, but accumulation should wait for proof. The debate turns on whether Q3–Q4 can deliver **reported PAT growth**. If profit stays flat or negative YoY despite continued revenue growth, the squeeze is structural and guidance is at risk. If it turns positive—even modestly—the commodity gap is closing and the bull case validates.
The verdict: **Hold.** Strong long-term order visibility and execution track record merit a patient stance, but the margin squeeze is real and unresolved. The single number to track from here is reported PAT growth in Q3 and Q4. Until that inflects positive, this is a waiting game, not a buy.
Record revenue masks margin squeeze; order book strong but commodity headwinds persist
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
FY27 revenue guidance on track (₹2,500 Cr in 9M toward ₹4,500 Cr). Margin guidance maintained but commodity escalation gap suggests execution risk.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong order visibility (₹13 Cr book) and guidance held firm support multi-year growth, but Q2 PAT down 6.8% YoY despite 19% revenue growth exposes margin fragility. Commodity volatility (aluminum +40% Q1–Q2) unresolved; NGT suspension of Signature Global (₹15 Cr/month) is a material near-term headwind.
₹770.9 Cr
Revenue · +19.3% YoY₹47.6 Cr
Reported PAT · −6.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest ever quarterly revenue of ₹771 Cr; 19% YoY growth
METDelivered ₹770.9 Cr, YoY +19.3%. Supported by 13-Cr order book at Sept 2026.
EBITDA margin 15.5% Q2; PAT margin 6.1%; both on track
OVERSTATEDDelivered OPM 15.4%, NPM 6.1%, PAT ₹47.6 Cr vs ₹51 Cr Q2-FY26. Margin compression -6.8% YoY.
Order inflow ₹2,487 Cr in FY27 YTD; FY28 target ₹4,000 Cr achievable
METOrder book ₹13,013 Cr as of Sept 30; bid pipeline ₹3,270 Cr. FY27 run rate ~₹2,800 Cr annualized.
Commodity cost escalation mitigated by contractual pass-through; 100% private sector has pass-through
PartialManagement acknowledges 2% margin gap in Q1, narrowed in Q2. Aluminum formwork cost jumped 40% (₹10.5k→₹14.5k/sqm) but expects recovery. Gap still present.
Strong execution; working capital cycle reduced 11 days QoQ vs Q1
METContract assets ₹2,279 Cr (18–20% of prior 12M revenue), debtors ₹1,300 Cr. WC days fell from high levels but still elevated.
Earnings quality
What changed since the last call
Margin pressure acknowledged; commodity escalation gap narrowing
NeutralQ1 escalation gap was 35%; Q2 narrowed to 2% per MD. But absolute commodity prices (aluminum ₹14,500/sqm vs ₹10,500) remain elevated vs pre-war. No revision to 15.5–16.5% EBITDA guidance, but management flagged Q4 revisit if commodity volatility persists.
Order book quality upgrade; new client Mahindra Lifespace
UpgradeMahindra Lifespace added as large new client. Order book ₹13,013 Cr (Sept 30) vs ₹12,000+ Cr implied Q1. 54% public, 46% private — skew toward higher-margin private sector projects vs FY26.
NGT impact quantified; Signature Global suspended for ~15 days Q2
DowngradeNovember 5–20 embargo expected; ~20-day suspension per MD commentary. Run rate ₹15 Cr/month implies ₹7–10 Cr miss in Q3 if extended. Not new risk, but now framed as 'force measure,' likely to recur in Q4.
Working capital days improved 11 days vs Q1; debtors ₹1,300 Cr at 120-day cycle
UpgradeDebtors ECL provisioning normalized post-Q1. Total receivables (certified + unbilled) ₹2,400 Cr net basis, ~77–85% of 12M revenue (vs 18–20% contract asset ratio). Improvement trajectory sustained.
The Q&A
Analysts pressed hard on margin recovery path amid commodity volatility. MD held firm on 15.5–16.5% EBITDA guidance but conceded Q4 revisit likely. NGT risk questioned; MD downplayed near-term impact but acknowledged 'force measures.' Labor availability during elections raised; MD assured no impact seen yet. Working capital probed deeply; MD transparent on debtors, contract assets, and milestone billing delays. No evasion; tone remained confident but cautious.
Contract assets retention — Rajesh Jain, RK Capital
AnsweredRetention money ₹170 Cr steady. Contract assets increasing with revenue. Debtors at ₹1,300 Cr (~120 days). Total receivables ₹2,400 Cr net basis, ~77–85% of full-year guidance.
Project-wise contribution — Dhananjay Mishra, Centrum Broking
AnsweredCIDCO ₹178 Cr (can go up to ₹2 Cr/month). MHADA ₹123 Cr. Signature Global ₹95 Cr. Raymonds ₹100 Cr. Downtown ₹111 Cr. M3M ₹60 Cr. Combined MGCM Bhandup ₹63 Cr. Maldives ₹69 Cr.
Next two-quarter run rate & FY28 target — Dhananjay Mishra, Centrum Broking
PartialWe are positioned to cross ₹300 Cr quarterly run rate by Q4. FY28 target ₹4,000 Cr revenue already factored in. No pressure; bid pipeline ₹3,270 Cr.
Labor availability & elections impact — Tammay Jain, Dolat Capital
AnsweredIndia can't work >10 months/year due to elections. Q1 saw dip due to Bengal elections. We've factored ₹45–50 Cr revenue loss. No reason to change full-year targets.
Aluminum & commodity escalation — Tammay Jain, Dolat Capital
PartialTotal formwork purchase ₹64.2 Cr planned (₹127 Cr spent H1). Current aluminum ₹14,500/sqm vs ₹10,500 pre-war. Can come down to ₹12,000–12,500. No impact on PAT if government escalation clauses match market inflation.
Capex vs revenue growth alignment — Tammay Jain, Dolat Capital
AnsweredCapex directly proportional to order intake. Fixed asset turnover 4.7% maintained. Cash PAT margin within 10.5–11.5% target range. No reason to change guidance.
MHADA CIDCO run rate Q3–Q4 — Vasudev Ganatra, Nuvama
AnsweredCIDCO first 6M: ₹177 Cr, ~₹30 Cr/month. Expecting 35–40% increase Q3–Q4. Next year run rate not <₹50 Cr/month, implying ₹600 Cr FY27.
Signature Global NGT impact & recovery — Vasudev Ganatra, Nuvama
PartialSignature Global impacted by NGT. Run rate ₹15 Cr/month. Once Phase 1 ready (titanium excluded), should reach ₹18–19 Cr/month. Commodity gap narrowed in Q2 vs Q1.
FY27 revenue guidance reiteration — Parth Thakkar, JM Financial
AnsweredFY27 guidance maintained at ₹4,500 Cr. Already crossed ₹2,500 Cr in 9M. With bid pipeline ₹3,270 Cr, we are confident of surpassing guidance.
EBITDA margin & cash PAT margin guidance — Deepak Poddar, Sapphire Capital
AnsweredEBITDA margin guidance 15.5–16.5%. Cash PAT margin 10.5–11.25%. Both held firm if commodity escalation matches government WPI.
Bottom-line growth vs margin improvement — Deepak Poddar, Sapphire Capital
PartialLast year recovery from bad debt + non-core asset sale boosted H1 PAT. Company has assets ₹48 Cr for held sale in FY27. Margin profile next FY will show uptick.
Long-term margin strategy — Diwakar Rana, Prudent Equity
PartialCompany continues seeking profitable orders. Order mix strongly supports 15.5–16.5% EBITDA. Won't digress into low-margin infrastructure. Margin profile will improve next FY as Maldives project ramps.
Debt & leverage trajectory — Diwakar Rana, Prudent Equity
AnsweredDebt level ₹80 Cr invested in capex. Repayment ~₹10 Cr/month. By March 31, we'll see net debt fall in line with March 26 numbers. No significant buildup expected.
Public-private project mix & profitability — Parikshit Gupta, Fair Value Capital
AnsweredMix maintained at ~55% govt, 45% private. Ideally 55% govt, 45% private — project values higher in private sector (no sharing like public). Won't chase low-margin govt work.
Pledged shares & promoter commitment — Parikshit Gupta, Fair Value Capital
AnsweredNo change. Reduced pledge by ₹35 lakhs this year. Only 50 lakhs shares pledged left (vs ₹608 Cr initial limit). Safe pledge for working capital limits via SBI project-specific. No future pledges to NBFCs.
NBCC run rate & project specifics — Tammay Jain, Dolat Capital
AnsweredNBCC: crossed ₹60 Cr run rate; targeting ₹65–70 Cr/month. IIT Bombay: only location handed over ₹70 Cr against ₹550 Cr order. Expect full frontage by March 27; ₹60 Cr/quarter thereafter.
Water scarcity & construction delays — Dhananjay Mishra, Centrum Broking
AnsweredUrban area construction company. No major rain impact or water shortages yet. If drastic measures, we'll keep stakeholders informed.
CIDCO profitability delay — Rohit Gupta, RKG Online
DodgedBoard meeting cleared it. Hopefully next 10 days we'll share good news.
Organizational structure & CEO appointments — Rohit Gupta, RKG Online
AnsweredProjects getting complex. We appointed CEOs for 4 BUs (BU1, BU2, BU3, BU4) with revenue + profit targets. Dividing businesses into strategic units for accountability.
Non-core asset recovery — Mayank Kothari, ???
AnsweredHeld ₹48 Cr assets for sale in FY27. H1 physical recovery ₹5–6 Cr. Expect ₹52–54 Cr total by year-end. FY28: ₹100–150 Cr residual. Subject to pricing & settlement agreements.
Guidance
FY27 ₹4,500 Cr (from prior Q1 call)
HighAlready ₹2,500+ Cr in 9M; on track. Remaining ₹1,900–2,000 Cr in Q4 requires ₹475–500 Cr/month, achievable per MD.
FY28 ₹4,000+ Cr (implied from MD commentary)
MediumBid pipeline ₹3,270 Cr; target ₹1,000 Cr order inflow. MHADA ramp + CIDCO expansion + new wins support 40%+ growth path.
EBITDA margin 15.5–16.5% FY27
MediumQ2 at 15.5% (mid-band). Commodity escalation gap narrowed Q1→Q2 (35% → 2%). Dependent on WPI tracking contractual escalation; caveat added for Q4 revisit.
Cash PAT margin 10.5–11.25%
MediumQ2 PAT margin 6.1% (reported); cash PAT guidance excludes depreciation (₹35 Cr quarterly) and non-core items. Last-year comparison inflated by bad-debt recovery.
₹135–140 Cr total capex FY27 (budgeted)
HighH1 ₹127 Cr spent (₹64.2 Cr formwork, ₹10.57 Cr plant). Remaining ₹8–13 Cr in H2. Focus: aluminum formwork procurement & equipment for order execution.
Risks the call surfaced
Commodity inflation
HighAluminum formwork cost jumped 40% (₹10,500 → ₹14,500/sqm). Steel +30%. Contractual pass-through lagging; Q1 gap 35%, Q2 narrowed to 2%. If government WPI doesn't track market, margin miss on fixed-price contracts.
NGT suspension risk
HighNational Green Tribunal (NGT) suspended construction ~15 days in Q2 (Graphs 2, 3). MD indicated November 5–20 embargo expected, likely 20-day suspension. Signature Global run rate ₹15 Cr/month; suspension implies ₹7–10 Cr revenue miss per event. Recurrence likely in Q4 (elections period).
Working capital intensity
MediumContract assets at ₹2,279 Cr (18–20% of trailing 12M revenue). Debtors ₹1,300 Cr at 120-day cycle. Total receivables ₹2,400 Cr net = ~77–85% of full-year revenue guidance. Milestone billing delays on CIDCO (board clearance pending) compress H2 collections; working capital days may remain elevated.
Order execution & project delays
MediumCIDCO profitability realization delayed (board clearance pending per Rohit Gupta Q&A). IIT Bombay only location handed over (₹70 Cr vs ₹550 Cr order); land handover delays. NBCC run rate gradual ramp. If execution lags, Q3–Q4 revenue targets at risk.
Labor availability during elections
MediumUP elections in Q4 FY27 expected to reduce work availability. India cannot work >10 months/year due to election cycles. Q1 saw dip from Bengal elections. MD factored ₹45–50 Cr revenue loss; if election period extends, impact could exceed.
Management
Score 8/10. Clear, granular, well-structured. MD provided specific numbers on project run-rates, client mix, capex details. Transparent on challenges (NGT, commodities, delays). No evasion except on CIDCO profitability (board review pending). Strong track record on order book growth (₹13 Cr vs ₹12 Cr implied Q1). Revenue guidance on track (₹2,500 Cr in 9M toward ₹4,500 Cr). Margin guidance maintained but under pressure; working capital improving. One concern: profit growth lagging revenue (+13% H1 revenue vs -11% H1 PAT).
1 · Q3–Q4 FY27
MHADA ramp-up: 25 towers handed, INR 4,200–4,300 Cr revenue expected. Sector 8, 9 filing underway.
2 · Q3–Q4 FY27
CIDCO scope expansion: INR 177 Cr H1 run rate; targeting 35–40% increase in H2, INR 600 Cr FY27.
3 · Q3 FY27
Signature Global NGT suspension relief; return to ₹15 Cr/month run rate.
Commodity volatility (aluminum +40% Q1–Q2) unresolved; NGT suspension of Signature Global (₹15 Cr/month) is a material near-term headwind.